The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for two new formulations of ViiV ...

Ten years after the signing of ground-breaking licensing agreements between ViiV Healthcare and the Medicines Patent Pool ...

ViiV Healthcare, a pharmaceutical company developing HIV therapies, and other plaintiffs sued Hetero USA on May 3 in Delaware District Court over patent infringement claims. The court action ...

Months before that, ViiV Healthcare rolled out Backseat Hotseat, a campaign to normalize conversations about HIV prevention, with the help of comedians Phoebe Robinson and Matteo Lane. Over the course ...

Pharma’s pandemic-era halo is slipping. After tracking a surge in the industry’s reputation, PatientView found patient groups ...

UK MHRA grants marketing approval for ViiV Healthcare’s cabotegravir formulations to help prevent HIV-1 infection in adults and adolescents: United Kingdom Saturday, May 4, 2024 ...

Allied Market Research published a report, titled, “HIV Injection Market by Distribution Channel (Hospital Pharmacy, Drug Stores and Retail Pharmacies, and Others): Global Opportunity Analysis and ...

GSK now expects core profits to rise by 9% to 11% this year, up from an earlier prediction of 7% to 10%, with a sales ...

“We believe in the potential that CAB-LA can have on changing the trajectory of the HIV epidemic,” said Dr Harmony Garges, ...

Image Cabenuva, an H.I.V. treatment, is a combination of two drugs.Credit...ViiV Healthcare, via Associated Press Long-acting drugs might be useful even for children living with H.I.V. Worldwide ...

SAN ANTONIO — HIV is no longer a death sentence for those who live with it, and new therapies with benefits lasting longer ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Nicole LaBrosse, Chief Financial Officer, is ...